A lot of advances in medicine are driven by individual investigators with a passion to solve a medical problem and improve outcomes. They go above and beyond. Nights, weekends. Barriers. Disappointments. With or without institutional support. They do this despite the fact that they usually don’t gain anything financially, and often make far less money to pursue their passion for research. Their main reward is the progress itself, and that’s sufficient. Yes, some do receive recognition, awards, and fame, but for most of my colleagues that’s not the driver of why they do what they do.

Just in time for #ASH25 MRD in Myeloma: all your questions answered! How to use MRD assessment in practice and research. @ZanwarSaurabh @LeukemiaJnl For a limited time get free access through this link: nam12.safelinks.protection.o… The principles we discuss apply for all cancers. We discuss its use as -Prognostic marker -Regulatory endpoint -Integral Biomarker to change therapy -Marker of Cure @MayoCancerCare @Myeloma_mSMART @MyelomaTeacher @mtmdphd @IMFmyeloma #IMFASH25